지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 저널정보
- 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제17권 제2호
- 발행연도
- 2016.1
- 수록면
- 539 - 543 (5page)
이용수
초록· 키워드
오류제보하기
Background: It is well known that peritoneal carcinomatosis (PC) from colorectal cancer (CRC) is associated with a poor prognosis. However, data on the prognostic significance of modern chemotherapy containing bevacizumab, cetuximab or panitumumab are not available. Materials and Methods: This retrospective review concerned 526 patients with metastatic CRC who were classified into two groups according to the presence or absence of PC, and were treated with systemic chemotherapy, with or without bevacizumab or anti-EGFR antibodies. The genetic background, in particular KRAS, BRAF, and PIK3CA gene mutations, and overall survival (OS) were compared between the two groups. Results: The median OS values were 23.3 and 29.1 months for PC and non-PC patients, respectively (hazard ratio [HR]=1.20; p=0.17). Among all patients, tumor location, number of metastatic sites and BRAF mutation status were significant prognostic factors, whereas the presence of PC was not. In the PC group, chemotherapy with bevacizumab resulted in a significantly longer OS than forchemotherapy without bevacizumab (HR=0.38, p<0.01), but this was not the case in the non-PC group (HR=0.80, p=0.10). Furthermore, the incidence of the BRAF V600E mutation was significantly higher in PC than in non-PC patients (27.7% versus 7.3%, p<0.01). BRAF mutations displayed a strong correlation with shorter OS in non-PC (HR=2.26), but not PC patients (HR=1.04). Conclusions: Systemic chemotherapy, especially when combined with bevacizumab, improved survival in patients with PC from CRC as well as non-PC patients. While BRAF mutation demonstrated a high frequency in PC patients, but it was not associated with prognosis.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Distribution of KRAS and BRAF Mutations in Metastatic Colorectal Cancers in Turkish Patients
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Mutation Analysis of KRAS and BRAF Genes in Metastatic Colorectal Cancer: a First Large Scale Study from Iran
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Utility of BRAF VE1 Immunohistochemistry as a Screening Tool for Colorectal Cancer Harboring BRAF V600E Mutation
Journal of Pathology and Translational Medicine
2018 .01
-
The Clinical Significance of the BRAF Mutation in Patients with Papillary Thyroid Cancer
The Journal of Endocrine Surgery
2017 .01
-
KRAS, NRAS, and BRAF mutations in plasma cell myeloma at a single Korean institute
Blood Research
2020 .01
-
Sensitivity and Usefulness of VE1 Immunohistochemical Staining in Acral Melanomas with BRAF Mutation
Annals of Dermatology
2018 .01
-
KRAS Mutation as a Biomarker for Survival in Patients with Non-Small Cell Lung Cancer, A Meta-Analysis of 12 Randomized Trials
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
BRAF Mutation Status and Clinicopathologic Characteristics in Colorectal Adenocarcinoma
대한임상종양학회 학술대회지
2015 .02
-
Clinicopathologic Significance of BRAF Mutation and Extracellular Signal Regulated Kinase 1/2 Expression in Patients With a Colorectal Adenocarcinoma
Annals of Coloproctology
2015 .01
-
Assessment of the Risk of Colorectal Cancer Survivors Developing a Second Primary Pancreatic Cancer
Gut and Liver
2017 .01
-
Correlation between RAS Test Results and Prognosis of Metastatic Colorectal Cancer Patients: a Report from Western Iran
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Status of extended RAS and BRAF mutations according to the microsatellite instability status and associated clinical features in patients with colorectal cancer
대한외과학회 학술대회 초록집
2017 .11
-
BRAF-Mutated Colorectal Cancer Exhibits Distinct Clinicopathological Features from Wild-Type BRAF-Expressing Cancer Independent of the Microsatellite Instability Status
Journal of Korean Medical Science
2017 .01
-
Systemic Inflammatory Biomarkers, Especially Fibrinogen to Albumin Ratio, Predict Prognosis in Patients with Pancreatic Cancer
Cancer Research and Treatment
2021 .01
-
Detecting Early Pancreatic Cancer: Current Problems and Future Prospects
Gut and Liver
2020 .01
-
Induction of Resistance to BRAF Inhibitor Is Associated with the Inability of Spry2 to Inhibit BRAF-V600E Activity in BRAF Mutant Cells
Biomolecules & Therapeutics(구 응용약물학회지)
2015 .01
-
Null Association between BRAF V600E Mutation and Tumor Recurrence in Patients with Papillary Thyroid Microcarcinoma in South Korea
International Journal of Thyroidology
2021 .11
-
갑상선 종양에서 RASSF1A 메틸화와 BRAF 유전자변이에 관한 연구
International Journal of Thyroidology
2018 .01
-
Prevalence and Prognostic Role of PIK3CA/AKT1 Mutations in Chinese Breast Cancer Patients
Cancer Research and Treatment
2019 .01
-
A study of pathological characteristics and BRAF V600E status in Langerhans cell histiocytosis of Vietnamese children
Journal of Pathology and Translational Medicine
2021 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0